Published in
Springer, Drug Safety, 7(39), p. 697-707, 2016
DOI: 10.1007/s40264-016-0414-0
Links
- Springer | PDF
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
Tools
Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors
Journal article published in 2016 by
Sirarat Sarntivijai 
,
Shelley Zhang,
Desikan G. Jagannathan,
Shadia Zaman,
Keith K. Burkhart,
Gilbert S. Omenn,
Yongqun He ,
Brian D. Athey,
Darrell R. Abernethy
,
Shelley Zhang,
Desikan G. Jagannathan,
Shadia Zaman,
Keith K. Burkhart,
Gilbert S. Omenn,
Yongqun He ,
Brian D. Athey,
Darrell R. Abernethy
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 